EClinCloud Launches Integrated Clinical Trial Cloud Platform to Enable System Interoperability and Improve Clinical Trial Speed and Efficiency

On 7/17, EClinCloud (Shenzhen) Technology Co., Ltd. ("EClinCloud") successfully held the Integrated Clinical Trial Cloud Platform Launch Event themed "Digital Breakthrough: Rising Together with EClinCloud" at the Shangri-La Qiantan, Shanghai. At the event, EClinCloud launched its integrated clinical trial cloud platform and invited senior leaders from clinical medicine, innovative pharmaceutical companies, CRO companies, capital markets, and other fields to provide comprehensive, multi-dimensional analyses and insights on how to leverage information technology to navigate challenges and overcome bottlenecks in clinical trials.

The three co-founders jointly launch the EClinCloud Integrated Clinical Trial Platform
(From left: Chief Business Officer Su Quanyu, Chief Executive Officer Qin Long, and Chief Technology Officer Wu Weiping)
What Challenges Need to Be Overcome?
At present, clinical trials in China face various pain points, such as high R&D costs, long timelines, and low success rates. These pain points stem from various practical causes, such as difficulties in patient recruitment, low patient adherence, and information silos that are difficult to connect. Therefore, the current industry need is very clear: to build a patient-centric, end-to-end integrated digital clinical trial platform.
How Do We Achieve a Digital Breakthrough?
The EClinCloud unified clinical trial cloud platform establishes unified data standards and, on a unified underlying architecture, uses a SaaS cloud platform as its foundation to achieve data interoperability across systems. In addition, EClinCloud integrates the concept of precise medical evaluation across its entire product line design, targeting current pain points in domestic R&D with targeted measures, helping sponsors obtain accurate clinical results more compliantly and efficiently.
The EClinCloud unified cloud platform comprises six stable, reliable, and straightforward systems, each with its own core advantages:
“
CTMS
Clinical Trial Management System
The EClinCloud CTMS Clinical Trial Management System helps sponsors and CROs implement efficient project management. It flexibly adapts to company workflows, supports one-click referencing of industry best-practice templates, delivers end-to-end project management and risk control, and reduces deployment time by 30% compared with peers.
eTMF - Electronic Trial Master File Management System
The EClinCloud eTMF Electronic Trial Master File Management System can help organizations rapidly build a high-quality, compliant TMF, meet regulatory requirements across countries worldwide, automatically name and intelligently file documents, and exchange data with CTMS.
eCOA - Electronic Clinical Outcome Assessment System
The EClinCloud eCOA Electronic Clinical Outcome Assessment System is patient-centric, focuses on precise medical evaluation in therapeutic areas, connects patients, sponsors, and research institutions, and features product delivery capabilities that meet international standards.
EDC - Electronic Data Capture System
The EClinCloud EDC Electronic Data Capture System is stable, reliable, straightforward, and easy to use, enables rapid database build with zero programming, provides extensive custom reporting, and interoperates with other applications on the platform.
RTSM - Randomization and Trial Supply Management System
The EClinCloud RTSM randomization and drug management system uses optimization algorithms to reduce drug waste, enables end-to-end tracking of drugs or devices, and interoperates with EDC, making it convenient for managers to view patient information without duplicate entry.
RM - Resource Management System
EClinCloud RM is a resource management system designed specifically for pharmaceutical companies and CRO companies. It not only manages contracts and timesheets, but also enables targeted cost control and scientific, effective project oversight and control.
Rising Together with EClinCloud
Compared with traditional technology companies, EClinCloud has a strong, experienced medical and scientific team that deeply understands industry pain points and connects client needs with industry expert resources from a professional medical perspective. In addition, as noted above, EClinCloud's systems are interconnected, resolving the information silos currently faced by many companies, improving R&D efficiency, reducing R&D costs, and delivering substantial value to clients. EClinCloud is also the exclusive strategic partner in Greater China of Signant Health, an established international clinical research informatics company. With a global perspective, EClinCloud can serve domestic companies' projects to international standards and, more importantly, help domestic pharmaceutical companies expand overseas.
EClinCloud wields digitalization to transform clinical research, laying the foundation for intelligent remote clinical research.

The Path to Digital Transformation from Different Perspectives
For the launch event's roundtable forum, EClinCloud invited Tom Tang, Senior Vice President at Adlai Nortye, to serve as moderator. Shen Yifeng, Director of the Clinical Trial Institution Office at Shanghai Mental Health Center; Lyu Cheng, Vice President of Translational Development and Clinical Operations at LianBio; Yu Dongsheng, General Manager of Galaxy Asset Management; and Zhang Hai, Senior Vice President of Clinical Services at Pharmaron Clinical, analyzed the progress, applications, and prospects of pharmaceutical R&D digitalization from the perspectives of capital markets, clinical medicine, innovative pharmaceutical companies, and CRO organizations.
Dr. Tang expressed strong confidence in EClinCloud's future prospects. He noted that in recent years, clinical research costs have risen year over year while productivity has declined, creating an urgent need for innovative pharmaceutical companies to improve efficiency, accelerate timelines, and reduce costs—making the outlook for digital clinical systems very promising.
Director Shen Yifeng stated that the benefits of clinical research digitalization should be viewed from both the patient and physician perspectives. From the patient perspective, standardized digital workflows and electronic completion methods can help patients express their true feelings more authentically and without interference. From the physician perspective, having guidance and oversight in the assessment process can help physicians use scales more scientifically.
Vice President Lyu Cheng stated that sponsors' core demands for clinical data are authenticity, convenience, and the ability to satisfy regulatory agencies' monitoring requirements, so they are very eager to learn patients' true feelings about clinical studies. Digital approaches will greatly reduce the difficulty of obtaining this information.
Vice President Zhang Hai stated that the founding teams of innovative pharmaceutical companies are mostly scientists who have relatively limited experience in clinical research project management, which is also why CRO companies exist. However, for CRO companies that need to conduct a massive number of projects simultaneously, having a system with clear, scientific management logic is also crucial.
General Manager Yu Dongsheng noted from a capital perspective that China is currently entering an aging society, domestic demand for new drug R&D is enormous, and the true core competitiveness of companies in the pharmaceutical sector lies in whether they have innovative capability. With the development of digitalization in China, the gains it brings can drive pharmaceutical innovation and meet domestic demand. Therefore, the clinical informatics sector has potential and room for growth, and it warrants greater attention.

Overall, in clinical research at the current stage, physicians, patients, sponsors, and CRO companies alike face numerous pressing issues to resolve and many areas needing improvement. Currently, EClinCloud has not only completed building an integrated platform, but the platform's application is also mature. Next, building on this foundation, EClinCloud will continue developing a DCT platform to enable remote execution across patient informed consent, data collection, project technology, and physician endpoint assessment, evolving into a landmark digital tool that can help clinical research advance better and faster.
How to watch the launch event livestream replay: On WeChat Channels, search for "EClinCloud" (一临云科技) and click "Livestream Replay"
About EClinCloud
EClinCloud provides an integrated unified cloud platform (including solutions such as CTMS, eTMF, EDC, RTSM, and eCOA, as well as consulting services such as scale management, linguistic validation, rater training, study build and configuration, and data quality analysis) and clinical trial endpoint assessment technologies across therapeutic areas (including oncology, neurology, cardiology, pulmonology, and dermatology). Combining cutting-edge technology with life data, it builds a world-leading, "patient-centric" SaaS cloud platform supporting clinical evidence to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs/devices, and benefit countless patients.


